Evidence map›Paper›PMID 39518158›Full record

ArticleCancers2024

Correction: Nelson et al.

Ryan S Nelson, Nathan D Seligson, Sal Bottiglieri, Estrella Carballido, Alex Del Cueto, Iman Imanirad, Richard Levine, Alexander S Parker, Sandra M Swain, Emma M Tillman and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer.International journal of molecular sciences · 2025
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

  • Erratum for
    2021
5 · Who and what money

Authors and funding

11 authors.

Ryan S NelsonDepartment of Consultative Services, ARUP Laboratories, Salt Lake City, UT 84108, USA.
Nathan D SeligsonDepartment of Pharmacotherapy and Translational Research, The University of Florida, Jacksonville, FL 32610, USA.ORCID 0000-0002-9670-3792
Sal BottiglieriDepartment of Pharmacy, Moffitt Cancer Center, Tampa, FL 33612, USA.ORCID 0000-0001-5344-3874
Estrella CarballidoDepartment of Oncological Sciences, University of South Florida, Tampa, FL 33612, USA.
Alex Del CuetoDepartment of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL 33612, USA.
Iman ImaniradDepartment of Oncological Sciences, University of South Florida, Tampa, FL 33612, USA.
Richard LevineDepartment of Oncological Sciences, University of South Florida, Tampa, FL 33612, USA.
Alexander S ParkerCollege of Medicine, University of Florida, Jacksonville, FL 32209, USA.
Sandra M SwainGeorgetown University Medical Center, MedStar Health, Washington, DC 20007, USA.
Emma M TillmanIndiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0001-8019-9811
J Kevin HicksDepartment of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL 33612, USA.ORCID 0000-0003-2314-0164

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication [...].

Identifiers

PMID39518158
PMCPMC11544884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.